Gathmann B, Mahlaoui N; CEREDIH; Gérard L, et al. European Society for Immunodeficiencies Registry Working Party. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014; 134: 116-26; https://doi.org/10.1016/j.jaci.2013.12.1077

Sullivan KE, Puck JM, Notarangelo LD, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol 2014; 34: 428-35; https://doi.org/10.1016/10.1007/s10875-014-0028-1

Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27: 308-16; https://doi.org/10.1007/s10875-007-9075-1

Thoré P, Jaïs X, Savale L, et al. Pulmonary Hypertension in Patients with Common Variable Immunodeficiency. J Clin Immunol 2021; 41: 1549-62; https://doi.org/10.1007/s10875-021-01064-w

Thoré P, Humbert M, Montani D. Pulmonary hypertension: A rare but severe complication of common variable immunodeficiency. Ann Allergy Asthma Immunol 2021; 127: 512-3; https://doi.org/10.1016/j.anai.2021.06.016

Daniil Z, Karetsi E, Zakynthinos E, et al. Pulmonary arterial hypertension in a patient with common variable immunodeficiency and unilateral bronchiectasis: Successful treatment with iloprost. Eur J Intern Med 2007; 18: 333-5; https://doi.org/10.1016/j.ejim.2006.11.014

Arslan S, Ucar R, Yavsan DM, et al. Common variable immunodeficiency and pulmonary amyloidosis: a case report. J Clin Immunol 2015; 35: 344-7; https://doi.org/10.1007/s10875-015-0151-7

Seidel MG, Kindle G, Gathmann B, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract 2019; 7: 1763; https://doi.org/10.1016/j.jaip.2019.02.004

Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract 2016; 4: 38; https://doi.org/10.1016/j.jaip.2015.07.025

Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913; https://doi.org/10.1183/13993003.01913-2018

D’Andrea A, Stanziola A, Di Palma E, et al. Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension. Echocardiography 2016; 33: 57; https://doi.org/10.1111/echo.12992

Nowak J, Hudzik B, Jastrzȩbski D, et al. Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation. Clin Respir J 2018; 12: 930; https://doi.org/10.1111/crj.12608

Stone AC, Machan JT, Mazer J, et al. Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease. Lung 2011; 189: 207; https://doi.org/10.1007/s00408-011-9293-4

Seeger W, Adir Y, Barberà JA, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 2013; 62: D109; https://doi.org/10.1016/j.jacc.2013.10.036

Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903-75; https://doi.org/10.1183/13993003.01032-2015

Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650; https://doi.org/10.1378/chest.06-1466

Budev MM, Arroliga AC, Wiedemann HP, et al. Cor pulmonale: an overview. Semin Respir Crit Care Med 2003; 24: 233; https://doi.org/10.1055/s-2003-41105

Kimura M, Taniguchi H, Kondoh Y, et al. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration 2013; 85: 456; https://doi.org/10.1159/000345221

Rich S. Primary pulmonary hypertension: executive summary. Evian, France. World Health Organization, 1998

Hurdman J, Condliffe R, Elliot CA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 2013; 41: 1292; https://doi.org/10.1183/09031936.00079512

Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995; 107: 1193; https://doi.org/10.1378/chest.107.5.1193

Weitzenblum E, Schrijen F, Mohan-Kumar T, et al. Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest 1988; 94: 772; https://doi.org/10.1378/chest.94.4.772

Snijders D, Fernandez Dominguez B, Calgaro S, et al. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence? Int J Immunopathol Pharmacol 2015; 28: 150-9; https://doi.org/10.1177/0394632015584724